Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: A potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation

Clinical Immunology

Volumn 132, Issue 2, 2009, Pages 184-194

  Niwa, Haruna ^a   Satoh, Takahiro ^a   Matsushima, Yuki ^a   Hosoya, Kazuki ^a   Saeki, Kazumi ^a   Niki, Toshiro ^b   Hirashima, Mitsuomi ^c   Yokozeki, Hiroo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b GalPharma Co Ltd   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Contact hypersensitivity; Galectin 9; Psoriasis; Regulatory T cells; Th17; Tim 3

Indexed keywords

ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTACT ALLERGY; CONTROLLED STUDY; EAR; IN VITRO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN CELL; SKIN DEFECT; SKIN INFLAMMATION; SWELLING; TH1 CELL; TH17 CELL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHEMOKINES; CROTON OIL; CYTOKINES; DERMATITIS, CONTACT; DERMATITIS, IRRITANT; DINITROFLUOROBENZENE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GALECTINS; INTERLEUKIN-17; INTERLEUKIN-23; KILLER CELLS, NATURAL; LIGANDS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PSORIASIS; RECEPTORS, VIRUS; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 67649958050     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.04.012     Document Type: Article

References (37)

1. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E.A., Coyle A.J., Sobel R.A., Freeman G.J., and Kuchroo V.K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 (2002) 536-541
2. Sanchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., Manlongat N., Bender O., Kamradt T., Kuchroo V.K., Gutierrez-Ramos J.C., Coyle A.J., and Strom T.B. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4 (2003) 1093-1101
3. Sabatos C.A., Chakravarti S., Cha E., Schubart A., Sanchez-Fueyo A., Zheng X.X., Coyle A.J., Strom T.B., Freeman G.J., and Kuchroo V.K. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4 (2003) 1102-1110
4. Oikawa T., Kamimura Y., Akiba H., Yagita H., Okumura K., Takahashi H., Zeniya M., Tajiri H., and Azuma M. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J. Immunol. 177 (2006) 4281-4287
5. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T.A., Kageshita T., Saita N., and Nakamura T. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 19 (2004) 593-600
6. Wada J., and Kanwar Y.S. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J. Biol. Chem. 272 (1997) 6078-6086
7. Wada J., Ota K., Kumar A., Wallner E.I., and Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J. Clin. Invest. 99 (1997) 2452-2461
8. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., and Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6 (2005) 1245-1252
9. Asakura H., Kashio Y., Nakamura K., Seki M., Dai S., Shirato Y., Abedin M.J., Yoshida N., Nishi N., Imaizumi T., Saita N., Toyama Y., Takashima H., Nakamura T., Ohkawa M., and Hirashima M. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J. Immunol. 169 (2002) 5912-5918
10. Imaizumi T., Kumagai M., Sasaki N., Kurotaki H., Mori F., Seki M., Nishi N., Fujimoto K., Tanji K., Shibata T., Tamo W., Matsumiya T., Yoshida H., Cui X.F., Takanashi S., Hanada K., Okumura K., Yagihashi S., Wakabayashi K., Nakamura T., Hirashima M., and Satoh K. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J. Leukoc. Biol. 72 (2002) 486-491
11. Anderson A.C., and Anderson D.E. TIM-3 in autoimmunity. Curr. Opin. Immunol. 18 (2006) 665-669
12. Koguchi K., Anderson D.E., Yang L., O'Connor K.C., Kuchroo V.K., and Hafler D.A. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 203 (2006) 1413-1418
13. Akiba H., Kehren J., Ducluzeau M.T., Krasteva M., Horand F., Kaiserlian D., Kaneko F., and Nicolas J.F. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168 (2002) 3079-3087
14. Wang B., Fujisawa H., Zhuang L., Freed I., Howell B.G., Shahid S., Shivji G.M., Mak T.W., and Sauder D.N. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165 (2000) 6783-6790
15. Xu H., Banerjee A., Dilulio N.A., and Fairchild R.L. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. J. Immunol. 158 (1997) 4721-4728
16. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., and Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
17. He D., Wu L., Kim H.K., Li H., Elmets C.A., and Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177 (2006) 6852-6858
18. Uyemura K., Yamamura M., Fivenson D.F., Modlin R.L., and Nickoloff B.J. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101 (1993) 701-705
19. Schlaak J.F., Buslau M., Jochum W., Hermann E., Girndt M., Gallati H., Meyer zum Buschenfelde K.H., and Fleischer B. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102 (1994) 145-149
20. Yawalkar N., Karlen S., Hunger R., Brand C.U., and Braathen L.R. Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 111 (1998) 1053-1057
21. Chan J.R., Blumenschein W., Murphy E., Diveu C., Wiekowski M., Abbondanzo S., Lucian L., Geissler R., Brodie S., Kimball A.B., Gorman D.M., Smith K., de Waal Malefyt R., Kastelein R.A., McClanahan T.K., and Bowman E.P. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203 (2006) 2577-2587
22. Toichi E., Torres G., McCormick T.S., Chang T., Mascelli M.A., Kauffman C.L., Aria N., Gottlieb A.B., Everitt D.E., Frederick B., Pendley C.E., and Cooper K.D. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J. Immunol. 177 (2006) 4917-4926
23. Krueger G.G., Langley R.G., Leonardi C., Yeilding N., Guzzo C., Wang Y., Dooley L.T., and Lebwohl M. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356 (2007) 580-592
24. Nakae S., Iwakura Y., Suto H., and Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81 (2007) 1258-1268
25. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V., and Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127 (2008) 78-88
26. Nishi N., Itoh A., Fujiyama A., Yoshida N., Araya S., Hirashima M., Shoji H., and Nakamura T. Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett. 579 (2005) 2058-2064
27. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
28. O'Leary J.G., Goodarzi M., Drayton D.L., and von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7 (2006) 507-516
29. Zaba L.C., Cardinale I., Gilleaudeau P., Sullivan-Whalen M., Suarez Farinas M., Fuentes-Duculan J., Novitskaya I., Khatcherian A., Bluth M.J., Lowes M.A., and Krueger J.G. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204 (2007) 3183-3194
30. Yokozeki H., Ghoreishi M., Takagawa S., Takayama K., Satoh T., Katayama I., Takeda K., Akira S., and Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 191 (2000) 995-1004
31. Takeshita K., Yamasaki T., Akira S., Gantner F., and Bacon K.B. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int. Immunol. 16 (2004) 685-695
32. Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.Y., Shinonaga R., Niki T., Nishi N., Tominaga A., Yamauchi A., and Hirashima M. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care. Med. 176 (2007) 27-35
33. Nobumoto A., Nagahara K., Oomizu S., Katoh S., Nishi N., Takeshita K., Niki T., Tominaga A., Yamauchi A., and Hirashima M. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 18 (2008) 735-744
34. Degauque N., Mariat C., Kenny J., Sanchez-Fueyo A., Alexopoulos S.P., Kuchroo V., Zheng X.X., and Strom T.B. Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins. Transplantation 84 (2007) S12-S16
35. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., Kasman I., Winer J., Modrusan Z., Danilenko D.M., and Ouyang W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178 (2007) 2229-2240
36. Bi S., Earl L.A., Jacobs L., and Baum L.G. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J. Biol. Chem. 283 (2008) 12248-12258
37. Makishi S., Okudaira T., Ishikawa C., Sawada S., Watanabe T., Hirashima M., Sunakawa H., and Mori N. A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells. Br. J. Haematol. 142 (2008) 583-594